Elena Medo says she sold her stock last year in Prolacta and says "worldwide the only competition have is my old company."
Medolac Laboratories (Neolac) will sell human-milk derived fortifier and other human-milk based products for use in both hospitals and at-home use. Prolacta, which recently expanded its facility to allow it to store as much as 110,000 litres of frozen human milk, sells its fortifier at a price of $6.25/ml, or $185/ounce.
Medo has secured suppliers of human milk by partnering with two organizations:
Current ads on Only The Breast, Oct. 20, 2013 |
Image from Mothers Milk Cooperative website. |
The ethical problems with Prolacta's model are obvious. The jury's still out on Medo's new model.
Sources: Interview with Medo, August 2013
PRNewswire, Medolac Laboratories and Mothers Milk Cooperative announce agreement
Elena Medo Linked-In Profile
News Release, Only The Breast announces innovative new milk banking partnership - Oct 18 2013 (via a receiving journalist)
-----
Previous Human Milk News posts on Prolacta.
Previous Human Milk News post on Only The Breast.
2 comments:
Jodine, do you know if Medolac provided any funding for the just-published study by Keim et al in Pediatrics? http://pediatrics.aappublications.org/content/early/2013/10/16/peds.2013-1687.abstract
From the study: "supported by a grant from The Ohio State University Food Innovation Center and internal support."
Post a Comment